Back to Search
Start Over
Macular thickness and visual acuity are characterized by a quadratic nonlinear relation in previously treated neovascular AMD eyes.
- Source :
-
European journal of ophthalmology [Eur J Ophthalmol] 2025 Mar; Vol. 35 (2), pp. 650-659. Date of Electronic Publication: 2024 Aug 02. - Publication Year :
- 2025
-
Abstract
- Purpose: To assess the associations between visual acuity (VA) and retinal thickness in age-related macular degeneration (AMD) eyes treated with anti-vascular endothelial growth factor (VEGF) therapy.<br />Methods: Sixty-eight patients with neovascular AMD (68 eyes) undergoing anti-VEGF therapy with two years of follow-up imaging data after the initiation of treatment were retrospectively included. Linear and nonlinear regression analyses with curve fitting estimation were performed to explore the relationship between visual acuity and OCT-based parameters at the 3-month and 24-month follow-up visits. Regression analyses were also performed between visual acuity and the retinal thickness deviation which was calculated as the absolute value of the difference between measured and normative retinal thickness values.<br />Results: The VA was not associated with either foveal (R <superscript>2 </superscript> = 0.011 and p = .401 at 3 months; R <superscript>2 </superscript> = 0.032 and p = .142 at 24 months) or parafoveal (R <superscript>2 </superscript> = 0.045 and p = .081 at 3 months; R <superscript>2 </superscript> = 0.050 and p = .055 at 24 months) retinal thicknesses. Compared with the linear models, a quadratic function yielded a relative increase in the R <superscript>2</superscript> coefficients. Conversely, the VA was linearly associated with foveal retinal thickness deviation (R <superscript>2 </superscript> = 0.041 and p = .037 at 24 months) and parafoveal retinal thickness deviation (R <superscript>2 </superscript> = 0.062 and p = .040 at 3 months; R <superscript>2 </superscript> = 0.088 and p = .014 at 24 months) values.<br />Conclusions: Although there was no linear relationship between retinal thickness and VA, a weak but statistically significant linear relationship could be observed when a retinal thickness deviation was considered. This suggests that deviation-based parameters may be beneficial for structure-function correlations in the context of anti-VEGF therapy for neovascular AMD.<br />Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Subjects :
- Humans
Male
Female
Retrospective Studies
Aged
Aged, 80 and over
Macula Lutea pathology
Macula Lutea diagnostic imaging
Bevacizumab therapeutic use
Follow-Up Studies
Fluorescein Angiography
Middle Aged
Retina physiopathology
Retina pathology
Visual Acuity physiology
Tomography, Optical Coherence
Angiogenesis Inhibitors therapeutic use
Vascular Endothelial Growth Factor A antagonists & inhibitors
Wet Macular Degeneration drug therapy
Wet Macular Degeneration physiopathology
Wet Macular Degeneration diagnosis
Ranibizumab administration & dosage
Ranibizumab therapeutic use
Intravitreal Injections
Subjects
Details
- Language :
- English
- ISSN :
- 1724-6016
- Volume :
- 35
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- European journal of ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 39094557
- Full Text :
- https://doi.org/10.1177/11206721241265998